Research article · 12 Jun 2025
Conference abstractPublished 2015
Simultaneous estimation of Olmesartan Medoxomil and Indapamide in tablet dosage form by spectroscopic method
Rucha A Patel, Hasumati A Raj, Meera V Lad and Richa A Dayaramani
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Olmesartan medoxomil and indapamide combination is used in cardiac disease condition like hypertension. Sustain release tablet formulation comprising olmesartan, medoxomil and indapamide. Patent for formulation is patented in china by Ministry of cardiovascular disease institute and patent for treatment for hypertension is patented in Japan. Olmesartan medoxomil was approved in USFDA on April, 2002 at New York and indapamide was approved in Lipha pharmaceutical institute on July 1998. Extensive literature survey related spectroscopy, high performance liquid chromatography, high performance thin layer chromatography, Reverse phase high performance liquid chromatography DAD method for estimation of Olmesartan medoxomil and Indapamide. Here thirteen analytical methods available for olmesartan medoxomil and twenty six analytical methods available for olmesartan medoxomil and its combination. And four analytical methods available for Indapamide, and nine analytical methods available for indapamide and its combination, seven analytical methods available for stability study for olmesartan, three analytical methods available for stability study for indapamide with other combination and no analytical method found for indapamide alone and for combination of olmesartan medoxomil and Indapamide, which indicates the need for analytical method development for Olmesartan medoxomil and Indapamide. Here attempt was made to develop and validate a sensitive, reproducible and specific spectroscopy method for Olmesartan medoxomil and Indapamide combination
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Rucha A Patel”
- BylineArticles whose byline prints “Hasumati A Raj”
- BylineArticles whose byline prints “Meera V Lad”
- BylineArticles whose byline prints “Richa A Dayaramani”
